Search Results

There are 64192 results for: content related to: HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV

  1. You have free access to this content
    Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus

    Hepatology

    Volume 62, Issue 3, September 2015, Pages: 932–954, AASLD/IDSA HCV Guidance Panel

    Version of Record online : 4 AUG 2015, DOI: 10.1002/hep.27950

  2. You have free access to this content
    Poster Session 2: Hepatitis C: Therapeutics (Approved Agents)

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 714A–807A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28228

  3. You have full text access to this OnlineOpen article
    Global distribution and prevalence of hepatitis C virus genotypes

    Hepatology

    Volume 61, Issue 1, January 2015, Pages: 77–87, Jane P. Messina, Isla Humphreys, Abraham Flaxman, Anthony Brown, Graham S. Cooke, Oliver G. Pybus and Eleanor Barnes

    Version of Record online : 28 JUL 2014, DOI: 10.1002/hep.27259

  4. You have free access to this content
    Poster Session IV (Abstracts 1638 – 2112)

    Hepatology

    Volume 64, Issue S1, October 2016, Pages: 811–1050,

    Version of Record online : 1 OCT 2016, DOI: 10.1002/hep.28800

  5. Steatosis is the predictor of relapse in HCV genotype 3- but not 2-infected patients treated with 12 weeks of pegylated interferon-α-2a plus ribavirin and RVR

    Journal of Viral Hepatitis

    Volume 19, Issue 5, May 2012, Pages: 346–353, L. Restivo, R. Zampino, B. Guerrera, L. Ruggiero and L. E. Adinolfi

    Version of Record online : 9 NOV 2011, DOI: 10.1111/j.1365-2893.2011.01555.x

  6. You have free access to this content
    HCV Therapeutics: Approved Agents

    Hepatology

    Volume 58, Issue S1, October 2013, Pages: 1091A–1168A,

    Version of Record online : 15 OCT 2013, DOI: 10.1002/hep.26880

  7. You have free access to this content
    Alisporivir plus ribavirin, interferon free or in combination with pegylated interferon, for hepatitis C virus genotype 2 or 3 infection

    Hepatology

    Volume 62, Issue 4, October 2015, Pages: 1013–1023, Jean-Michel Pawlotsky, Robert Flisiak, Shiv K. Sarin, Jens Rasenack, Teerha Piratvisuth, Wan-Long Chuang, Cheng-Yuan Peng, Graham R. Foster, Samir Shah, Heiner Wedemeyer, Christophe Hézode, Wei Zhang, Kelly A. Wong, Bin Li, Claudio Avila, Nikolai V. Naoumov and on behalf of the VITAL-1 study team

    Version of Record online : 10 AUG 2015, DOI: 10.1002/hep.27960

  8. You have full text access to this OnlineOpen article
    All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study

    Hepatology

    Volume 61, Issue 4, April 2015, Pages: 1127–1135, David R. Nelson, James N. Cooper, Jacob P. Lalezari, Eric Lawitz, Paul J. Pockros, Norman Gitlin, Bradley F. Freilich, Ziad H. Younes, William Harlan, Reem Ghalib, Godson Oguchi, Paul J. Thuluvath, Grisell Ortiz-Lasanta, Mordechai Rabinovitz, David Bernstein, Michael Bennett, Trevor Hawkins, Natarajan Ravendhran, Aasim M. Sheikh, Peter Varunok, Kris V. Kowdley, Delphine Hennicken, Fiona McPhee, Khurram Rana, Eric A. Hughes and on behalf of the ALLY-3 Study Team

    Version of Record online : 10 MAR 2015, DOI: 10.1002/hep.27726

  9. You have full text access to this OnlineOpen article
    Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis

    Hepatology

    Volume 61, Issue 3, March 2015, Pages: 769–775, Eric Lawitz, Fred Poordad, Diana M. Brainard, Robert H. Hyland, Di An, Hadas Dvory-Sobol, William T. Symonds, John G. McHutchison and Fernando E. Membreno

    Version of Record online : 30 JAN 2015, DOI: 10.1002/hep.27567

  10. You have free access to this content
    Is genotype 3 of the hepatitis C virus the new villain?

    Hepatology

    Volume 59, Issue 6, June 2014, Pages: 2403–2412, Nicolas Goossens and Francesco Negro

    Version of Record online : 14 APR 2014, DOI: 10.1002/hep.26905

  11. You have free access to this content
    Poster Session 4: Acute Liver Failure and Artificial Liver Support; Diagnostics, Epidemiology, and Natural History

    Hepatology

    Volume 62, Issue S1, October 2015, Pages: 1064A–1132A,

    Version of Record online : 7 OCT 2015, DOI: 10.1002/hep.28236

  12. Abstract of Papers Submitted to the American Association of the Study of Liver Disease

    Hepatology

    Volume 22, Issue S4, October 1995, Pages: S107–S514,

    Version of Record online : 5 DEC 2005, DOI: 10.1002/hep.1840220703

  13. You have free access to this content
    Abstracts 210 to 431

    Hepatology

    Volume 46, Issue S1, October 2007, Pages: 331A–430A,

    Version of Record online : 19 SEP 2007, DOI: 10.1002/hep.22017

  14. Abstract Index

    Journal of Gastroenterology and Hepatology

    Volume 19, Issue s7, December 2004, Pages: A676–A868,

    Version of Record online : 3 DEC 2004, DOI: 10.1111/j.1440-1746.2004.03735.x

  15. You have free access to this content
    Different distributions of hepatitis C virus genotypes among HIV-infected patients with acute and chronic hepatitis C according to interleukin-28B genotype

    HIV Medicine

    Volume 12, Issue 8, September 2011, Pages: 487–493, K Neukam, J Nattermann, N Rallón, A Rivero, A Caruz, J Macías, M Vogel, JM Benito, Á Camacho, JA Mira, C Schwarze-Zander, P Barreiro, A Martínez, JK Rockstroh, V Soriano and JA Pineda

    Version of Record online : 6 MAR 2011, DOI: 10.1111/j.1468-1293.2011.00912.x

  16. You have free access to this content
    AASLD Abstracts 1606–1960

    Hepatology

    Volume 48, Issue S1, October 2008, Pages: 1019A–1187A,

    Version of Record online : 24 SEP 2008, DOI: 10.1002/hep.22647

  17. You have free access to this content
    AASLD Abstracts (pp. 383A–483A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 383A–483A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840380506

  18. You have free access to this content
    Abstracts 1020 to 1278

    Hepatology

    Volume 42, Issue S1, October 2005, Pages: 598A–702A,

    Version of Record online : 5 OCT 2005, DOI: 10.1002/hep.20927

  19. OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naïve patients with HIV/HCV genotype 2/3 co-infection in Italy

    Liver International

    Volume 35, Issue 1, January 2015, Pages: 120–129, Raffaele Bruno, Giuseppe Cariti, Paola Nasta, Amedeo Capetti, Veronica Ravasio, Massimo Galli, Enzo Raise, Giulio Palmieri, Claudio Iannacone and Massimo Puoti

    Version of Record online : 11 AUG 2014, DOI: 10.1111/liv.12641

  20. You have free access to this content
    AASLD Abstracts (pp. 282A–382A)

    Hepatology

    Volume 38, Issue S4, October 2003, Pages: 282A–382A,

    Version of Record online : 10 FEB 2006, DOI: 10.1002/hep.1840380505